Please login to the form below

Not currently logged in
Email:
Password:

Avycaz

This page shows the latest Avycaz news and features for those working in and with pharma, biotech and healthcare.

Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

Allergan’ s Avycaz breaks Gram-negative pneumonia antibiotic drought. Becomes the first new drug to treat the condition in over 15 years. ... Avycaz proved non-inferior to meropenem on 28-day all-cause mortality, with rates of 9.6% and 8.3% respectively

Latest news

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics